Source:http://linkedlifedata.com/resource/pubmed/id/18055460
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2008-2-11
|
pubmed:abstractText |
We show that co-expression of interleukin 15 (IL-15) and IL-15 receptor alpha (IL-15Ralpha) in the same cell allows for the intracellular interaction of the two proteins early after translation, resulting in increased stability and secretion of both molecules as a complex. In the absence of co-expressed IL-15Ralpha, a large portion of the produced IL-15 is rapidly degraded immediately after synthesis. Co-injection into mice of IL-15 and IL-15Ralpha expression plasmids led to significantly increased levels of the cytokine in serum as well as increased biological activity of IL-15. Examination of natural killer cells and T lymphocytes in mouse organs showed a great expansion of both cell types in the lung, liver, and spleen. The presence of IL-15Ralpha also increased the number of CD44(high) memory cells with effector phenotype (CD44(high)CD62L-). Thus, mutual stabilization of IL-15 and IL-15Ralpha leads to remarkable increases in production, stability, and tissue availability of bioactive IL-15 in vivo. The in vivo data show that the most potent form of IL-15 is as part of a complex with its receptor alpha either on the surface of the producing cells or as a soluble extracellular complex. These results explain the reason for coordinate expression of IL-15 and IL-15Ralpha in the same cell and suggest that the IL-15Ralpha is part of the active IL-15 cytokine rather than part of the receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9258
|
pubmed:author |
pubmed-author:AliceaCandidoC,
pubmed-author:BergamaschiCristinaC,
pubmed-author:FelberBarbara KBK,
pubmed-author:JalahRashmiR,
pubmed-author:KulkarniVirajV,
pubmed-author:PatelVainavV,
pubmed-author:PavlakisGeorge NGN,
pubmed-author:RosatiMargheritaM,
pubmed-author:ValentinAntonioA,
pubmed-author:ZhangGen-MuGM
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4189-99
|
pubmed:meshHeading |
pubmed-meshheading:18055460-Cell Line,
pubmed-meshheading:18055460-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18055460-Humans,
pubmed-meshheading:18055460-Interleukin-15,
pubmed-meshheading:18055460-Interleukin-15 Receptor alpha Subunit,
pubmed-meshheading:18055460-Liver,
pubmed-meshheading:18055460-Lung,
pubmed-meshheading:18055460-Protein Binding,
pubmed-meshheading:18055460-Spleen
|
pubmed:year |
2008
|
pubmed:articleTitle |
Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
|
pubmed:affiliation |
Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, NCI-Frederick, National Instsitutes of Health, MD 21702-1201, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|